GB9926532D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9926532D0
GB9926532D0 GBGB9926532.4A GB9926532A GB9926532D0 GB 9926532 D0 GB9926532 D0 GB 9926532D0 GB 9926532 A GB9926532 A GB 9926532A GB 9926532 D0 GB9926532 D0 GB 9926532D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9926532.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GBGB9926532.4A priority Critical patent/GB9926532D0/en
Publication of GB9926532D0 publication Critical patent/GB9926532D0/en
Priority to PCT/EP2000/011035 priority patent/WO2001034795A2/en
Priority to AU15199/01A priority patent/AU1519901A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464499—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
GBGB9926532.4A 1999-11-09 1999-11-09 Novel compounds Ceased GB9926532D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9926532.4A GB9926532D0 (en) 1999-11-09 1999-11-09 Novel compounds
PCT/EP2000/011035 WO2001034795A2 (en) 1999-11-09 2000-11-08 Casb7435 polypeptide, nucleic acid encoding it, and their uses in treatment and diagnosis
AU15199/01A AU1519901A (en) 1999-11-09 2000-11-08 Novel compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9926532.4A GB9926532D0 (en) 1999-11-09 1999-11-09 Novel compounds

Publications (1)

Publication Number Publication Date
GB9926532D0 true GB9926532D0 (en) 2000-01-12

Family

ID=10864233

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9926532.4A Ceased GB9926532D0 (en) 1999-11-09 1999-11-09 Novel compounds

Country Status (3)

Country Link
AU (1) AU1519901A (en)
GB (1) GB9926532D0 (en)
WO (1) WO2001034795A2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL139686A0 (en) * 1998-06-02 2002-02-10 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same

Also Published As

Publication number Publication date
WO2001034795A3 (en) 2002-01-24
WO2001034795A2 (en) 2001-05-17
AU1519901A (en) 2001-06-06

Similar Documents

Publication Publication Date Title
EP1140083A4 (en) Novel compounds
GB9902084D0 (en) Novel compounds
GB9902697D0 (en) Novel compounds
GB9901256D0 (en) Novel compounds
GB9902937D0 (en) Novel compounds
GB9902880D0 (en) Novel compounds
GB9902070D0 (en) Novel compounds
GB9902077D0 (en) Novel compounds
GB9902088D0 (en) Novel compounds
GB9901368D0 (en) Novel compounds
GB9901462D0 (en) Novel compounds
GB9901463D0 (en) Novel compounds
GB9901465D0 (en) Novel compounds
GB9901602D0 (en) Novel compounds
GB9901903D0 (en) Novel compounds
GB9901944D0 (en) Novel compounds
GB9901945D0 (en) Novel compounds
GB9901946D0 (en) Novel compounds
GB9901947D0 (en) Novel compounds
GB9901948D0 (en) Novel compounds
GB9902009D0 (en) Novel compounds
GB9902069D0 (en) Novel compounds
GB9901078D0 (en) Novel compounds
GB9902074D0 (en) Novel compounds
GB9900959D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)